When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CHMA - Chiasma's octreotide shows sustained benefit in acromegaly extension study
Chiasma Inc.
Chiasma (NASDAQ:CHMA) announces 48-week data from the open-label extension (OLE) from the Phase 3 OPTIMAL trial evaluating Mycapssa (octreotide) in acromegaly patients.
More news on: Chiasma, Inc., Healthcare stocks news, Stocks on the move,